Hikma and Vectura collaborate to develop GSK generics

12-11-2018

Hikma and Vectura collaborate to develop GSK generics

Natee Meepian / iStockphoto.com

Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products. 


Hikma Pharmaceuticals, Vectura Group, GSK, Ellipta, FDA, generics, collaboration, inhaler device


LSIPR